It is really urgent to solve many problems related to childhood cancers on earth because more than 400,000 children suffer from cancer every year, among whom about 250,000 children live in Asia. The serious problem is that the cure rate of childhood cancer in low and lower-middle income countries is still 10 to 30 %, while that in high income countries almost 80%. Thus, there is unacceptable inequality in the children with cancer who live at the same time and on the same earth.

   To fight against cancer in children especially in Asia, we decided to found the childhood cancer clinical study group named as “Asian Pediatric Hematology and Oncology Group (APHOG)” in April, 2012, when the Asian continental congress of the International Society of Paediatirc Oncology (SIOP Asia) was held in Yogyakarta, Indonesia. APHOG is a children’s cancer clinical study group in Asia that intimately collaborates with SIOP Asia, an academic society. It conducts the clinical studies to develop new drugs, the discovery of novel candidate drugs, promotion of the childhood cancer registry and diagnosis, solution of the genetic problems of childhood cancers, support for the better survivorship, construction of the ICT-based children’s cancer global network system, and prevention of the late effects in Asia.

In 2018, the World Health Organization (WHO) collaborating with SIOP, the Union for International Cancer Control (UICC) and United Nation (UN), declared that the cure rate of childhood cancer on earth will be increased to more than 60% by 2030 (WHO Global Initiative for Childhood Cancer). APHOG will take at least a part of this action in Asia by collaborating with the above-mentioned organizations.

  NGO Magokoro Organization for Childhood Cancer (MOCC) is the foundation to support APHOG.  Your hearty and bona fide donation is very welcome. We accept your invaluable donation and support through MOCC.

                                                                                     Chair, Nakagawara Akira

nakagawa.png